Cerbios-Pharma News and Resources

HAS Healthcare Advanced Synthesis SA (HAS) has announced its acquisition of Cerbios-Pharma SA (Cerbios), a Switzerland-based manufacturer of chemical and biological active pharmaceutical ingredients (APIs). The transaction aims to enhance HAS’s capabilities in high-potency APIs and antibody-drug conjugates (ADCs), further solidifying its

Cerbios-Pharma has announced the opening of a new manufacturing expansion at its Lugano site, enhancing its capabilities for clinical and commercial production of Highly Potent Active Pharmaceutical Ingredients (HPAPIs). The facility will also support cytotoxic linker payloads for antibody-drug conjugates (ADCs).